Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis

Caroline Marty, Christian Pecquet, Harini Nivarthi, Mira El-Khoury, Ilyas Chachoua, Micheline Tulliez, Jean-Luc Villeval, Hana Raslova, Robert Kralovics, Stefan N. Constantinescu, Isabelle Plo, William Vainchenker

Blood (2016) 127 (10): 1317–1324.

https://doi.org/10.1182/blood-2015-11-679571

Published: 2016

Includes: Supplemental data

Journal Articles

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis

Solène Evrard, Olivier Bluteau, Micheline Tulliez, Philippe Rameau, Patrick Gonin, Eva Zetterberg, Jan Palmblad, Arnaud Bonnefoy, Jean-Luc Villeval, William Vainchenker, Stéphane Giraudier, Orianne Wagner-Ballon

Blood (2011) 117 (1): 246–249.

https://doi.org/10.1182/blood-2010-07-294447

Published: 2011

Includes: Supplemental data

Journal Articles

Increased Myelofibrosis in Thrombospondin-1-Null Mice Is Associated with Enhanced TGF-β1-Mediated Response by Bone Marrow Fibroblasts

Solène Evrard, Micheline Tulliez, MD, Eva Zetterberg, MD, PhD, Jan Palmblad, MD, PhD, William Vainchenker, MD, PhD, Jean-Luc Villeval, PhD, Stéphane Giraudier, MD, PhD, Orianne Wagner-Ballon, MD, PhD

Blood (2008) 112 (11): 2796.

https://doi.org/10.1182/blood.V112.11.2796.2796

Published: 2008

Journal Articles

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Chloe James, Frederic Mazurier, Sabrina Dupont, Ronan Chaligne, Isabelle Lamrissi-Garcia, Micheline Tulliez, Eric Lippert, François-Xavier Mahon, Jean-Max Pasquet, Gabriel Etienne, François Delhommeau, Stephane Giraudier, William Vainchenker, Hubert de Verneuil

Blood (2008) 112 (6): 2429–2438.

https://doi.org/10.1182/blood-2008-02-137877

Published: 2008

Journal Articles

Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice

Orianne Wagner-Ballon, Didier F. Pisani, Thomas Gastinne, Micheline Tulliez, Ronan Chaligné, Catherine Lacout, Frédéric Auradé, Jean-Luc Villeval, Patrick Gonin, William Vainchenker, Stéphane Giraudier

Blood (2007) 110 (1): 345–353.

https://doi.org/10.1182/blood-2006-10-054502

Published: 2007

Journal Articles

JAK2 V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis

Catherine Lacout, Didier F. Pisani, Micheline Tulliez, Françoise Moreau Gachelin, William Vainchenker, Jean-Luc Villeval

Blood (2006) 108 (5): 1652–1660.

https://doi.org/10.1182/blood-2006-02-002030

Published: 2006

Journal Articles

Proteasome Inhibitor Bortezomib Can Inhibit Bone Marrow Fibrosis Development in a Murine Model of Myelofibrosis.

Orianne Wagner-Ballon, MD, Thomas Gastinne, MD, Micheline Tulliez, MD, Catherine Lacout, Didier Pisani, PhD, Hedia Chagraoui, PhD, Jean-Luc Villeval, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2005) 106 (11): 2582.

https://doi.org/10.1182/blood.V106.11.2582.2582

Published: 2005

Journal Articles

Pericyte Coverage of Abnormal Blood Vessels in Myelofibrosis Bone Marrows.

Eva Zetterberg, MD, PhD, Alessandro M. Vannucchi, MD, Anna Rita Migliaccio, PhD, William Vainchenker, MD, PhD, Micheline Tulliez, MD, Renee Dickie, PhD, Rick Rogers, PhD, Jan Palmblad, MD, PhD

Blood (2005) 106 (11): 4936.

https://doi.org/10.1182/blood.V106.11.4936.4936

Published: 2005

Journal Articles

Adenoviral Mediated TGF-β1inhibition in a Murine Model of Myelofibrosis Can Prevent and Cure Bone Marrow Fibrosis Development.

Thomas Gastinne, MD, Orianne Wagner-Ballon, MD, Micheline Tulliez, MD, Hedia Chagraoui, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2004) 104 (11): 794.

https://doi.org/10.1182/blood.V104.11.794.794

Published: 2004

Journal Articles

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Hédia Chagraoui, Micheline Tulliez, Tarek Smayra, Emiko Komura, Stéphane Giraudier, Theodore Yun, Nathalie Lassau, William Vainchenker, Françoise Wendling

Blood (2003) 101 (8): 2983–2989.

https://doi.org/10.1182/blood-2002-09-2839

Published: 2003

Journal Articles

Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Hédia Chagraoui, Emiko Komura, Micheline Tulliez, Stéphane Giraudier, William Vainchenker, Françoise Wendling

Blood (2002) 100 (10): 3495–3503.

https://doi.org/10.1182/blood-2002-04-1133

Published: 2002

Journal Articles

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

Caroline Besson, Aicha Goubar, Jean Gabarre, Willy Rozenbaum, Gilles Pialoux, François-Patrick Châtelet, Christine Katlama, Frédéric Charlotte, Bertrand Dupont, Nicole Brousse, Michel Huerre, Jacqueline Mikol, Philippe Camparo, Karima Mokhtari, Micheline Tulliez, Dominique Salmon-Céron, François Boué, Dominique Costagliola, Martine Raphaël

Blood (2001) 98 (8): 2339–2344.

https://doi.org/10.1182/blood.V98.8.2339

Published: 2001

Journal Articles

HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma

Nicolas Dupin, Tim L. Diss, Paul Kellam, Micheline Tulliez, Ming-Qing Du, Didier Sicard, Robin A. Weiss, Peter G. Isaacson, Chris Boshoff

Blood (2000) 95 (4): 1406–1412.

https://doi.org/10.1182/blood.V95.4.1406.004k26_1406_1412

Published: 2000

Journal Articles

High Thrombopoietin Production by Hematopoietic Cells Induces a Fatal Myeloproliferative Syndrome in Mice

Jean-Luc Villeval, Karine Cohen-Solal, Micheline Tulliez, Stéphane Giraudier, Josette Guichard, Samuel A. Burstein, Elisabeth M. Cramer, William Vainchenker, Françoise Wendling

Blood (1997) 90 (11): 4369–4383.

https://doi.org/10.1182/blood.V90.11.4369

Published: 1997

NARROW

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis

Increased Myelofibrosis in Thrombospondin-1-Null Mice Is Associated with Enhanced TGF-β1-Mediated Response by Bone Marrow Fibroblasts

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice

JAK2 V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis

Proteasome Inhibitor Bortezomib Can Inhibit Bone Marrow Fibrosis Development in a Murine Model of Myelofibrosis.

Pericyte Coverage of Abnormal Blood Vessels in Myelofibrosis Bone Marrows.

Adenoviral Mediated TGF-β1inhibition in a Murine Model of Myelofibrosis Can Prevent and Cure Bone Marrow Fibrosis Development.

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma

High Thrombopoietin Production by Hematopoietic Cells Induces a Fatal Myeloproliferative Syndrome in Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only